MedTrace Logo

Finnish AntiCoagulation in Atrial Fibrillation (FinACAF)

NCT04645537 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400000

Last updated 2025-03-20

No results posted yet for this study

Summary

The aim of FINACAF study is to evaluate the incidence and risk of stroke, systemic thromboembolic events, myocardial infarction, major bleeding events, and mortality in relation to different attitudes regarding stroke prevention treatment among AF patients.

The study with cohort design is conducted as a nationwide retrospective register-based linkage study using data obtained from the Finnish health care registers.

Conditions

Sponsors & Collaborators

  • Aalto University

    collaborator OTHER

  • University of Turku

    collaborator OTHER

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Mika Lehto, MD,PhD · Helsinki University Central Hospital

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-01
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04645537 on ClinicalTrials.gov